Related Experiment Video

Updated: May 15, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Respiratory syncytial virus entry inhibitors targeting the F protein

Zhiwu Sun1, Yanbin Pan, Shibo Jiang

  • 1Key Laboratory of Medical Molecular Virology of Ministries of Education & Health, Shanghai Medical College and Institute of Medical Microbiology, Fudan University, Shanghai 200032, China. haoyunzhiwu@163.com

Viruses
|January 18, 2013
PubMed

Insights

Human respiratory syncytial virus (RSV) causes severe respiratory infections. New therapies targeting the RSV F protein are urgently needed due to limited treatment options and vaccine availability.

Area of Science:

  • Virology
  • Immunology
  • Drug Discovery

Background:

  • Human respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants and high-risk adults.
  • Current treatments and vaccines for RSV are limited, necessitating novel therapeutic strategies.
  • The RSV F protein is crucial for viral entry into host cells, making it a key target for intervention.

Purpose of the Study:

  • To review advances in understanding the structure and function of the RSV F protein.
  • To discuss the development of novel RSV entry inhibitors targeting the F protein.

Main Methods:

  • Review of scientific literature on RSV F protein structure and function.
  • Analysis of studies on the development of F protein-targeting RSV entry inhibitors.

Main Results:

  • The RSV F protein's role in viral entry is well-established.
  • Significant progress has been made in developing entry inhibitors targeting the F protein.
  • Structural and functional studies provide a basis for rational drug design.

Conclusions:

  • The RSV F protein represents a promising target for developing effective anti-RSV therapeutics.
  • Targeting viral entry via the F protein offers a potential strategy to combat RSV infections.
  • Continued research into F protein inhibitors is crucial for advancing RSV treatment options.

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...